Compare Axogen Inc (AXGN) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Axogen Inc trades at $48.21 (market cap $2.61B), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 31.4× Axogen Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | REGN | |
|---|---|---|
Market Cap | $2.61B | $82.06B |
Sector | Technology | Health |
52-Week High | $48.48 | $812.27 |
52-Week Low | $14.16 | $555.51 |
Enterprise Value | $2.52B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
